Search | WHO COVID-19 Research Database

Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine.

Avital, Dekel; Peretz, Shlomi; Perlow, Eliauh; Konen, Osnat; Inbar, Edna; Bulkowstein, Yarden; Nahum, Elhanan; Aharoni, Sharon; Vig, Lital Cohen; Nevo, Yoram; Auriel, Eitan; Straussberg, Rachel.

Eur J Paediatr Neurol ; 40: 40-43, 2022 Sep.

Article in English | MEDLINE | ID: covidwho-1966537

ABSTRACT

Pediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.

Subject(s)

COVID-19 , Cerebral Arterial Diseases , Stroke , COVID-19/complications , Cerebral Arterial Diseases/complications , Cerebral Arterial Diseases/diagnostic imaging , Cerebral Arterial Diseases/drug therapy , Child , Child, Preschool , Humans , Nimodipine/therapeutic use , SARS-CoV-2 , Stroke/diagnostic imaging , Stroke/drug therapy , Stroke/etiology

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL